Hydromer, Inc (HYDI) Fair Value & Analysis
Basic Materials · US · Market cap $716K
Fair value as of: Jun 23, 2026
Analysis
Hydromer, Inc (HYDI) currently trades at $0.2200, while our model-based Fair Value estimate is $1.19 — implying the stock looks roughly 440.9% undervalued today. We read business quality at 89/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products. The company also provides cosmetics and personal care products, and watercraft hulls coating products; and engineering and contract coating services. It serves the medical, cosmetics, animal health, and industrial fields. Hydromer, Inc. was founded in 1980 and is based in Branchburg, New Jersey.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Hydromer, Inc (HYDI) undervalued?
What is the fair value of HYDI?
What is the quality score of HYDI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.